Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-03-23-Speech-1-107"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20090323.15.1-107"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Safe cosmetic products are particularly important to European consumers, which is the reason why we must focus appropriate attention on them.
I regard as timely the initiative to review the directive and its replacement with a proposal for a regulation from the Commission. This will allow inaccuracies and inconsistencies of a legal nature to be eliminated and discrepancies to be avoided between transpositions into national legislation.
In circumstances where experience at a European level has demonstrated that the ‘ingredient by ingredient’ type approach is neither viable nor adequate, in my view, our priorities are to make manufacturers more accountable and to enforce tight control on the internal market.
The use of nanomaterials is a promising solution in this area, but they are to be assessed and declared safe by the Scientific Committee for products intended for consumer use, while the use of alternative methods is an initiative which must continue to be supported.
I believe that the involvement of the Committee which I referred to is vital with regard to the use of substances classified as carcinogenic, mutagenic or toxic in order to verify their use in the manufacture of cosmetic products.
In order to implement this regulation effectively, I believe that Member States must carry out adequate checks and, in the event of non-compliance, submit a report on a regular basis to the Commission."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples